F2 and myocardial infarction: Zhou et al. [21] found that 30% of COVID-19 patients have shortened prothrombin times, and coagulation dysfunction can lead to thrombosis on the surface of intravenous plaques and induce venous thrombosis, myocardial infarction, and other cardiovascular diseases.